ARPA-H ImagiNg Data EXchange (INDEX)
ID: ARPA-H-SOL-25-112Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Administrative and National Policy Requirements document outlines essential guidelines for proposal submissions in response to government RFPs. It mandates the inclusion of specific information regarding team members, organizational conflicts of interest, research security disclosures, and various ethical considerations related to human and animal subjects. The document emphasizes clarity in identifying team members, their affiliations, potential conflicts, and any foreign involvement. Additionally, it addresses intellectual property rights and expected deliverables, requiring detail on proprietary claims, patents, and usage intentions. It also stipulates regulatory compliance concerning human and animal research, software standards, and information management regarding controlled unclassified information. Overall, this document serves as a comprehensive framework to ensure proposals comply with federal regulations and ethical standards while facilitating effective oversight of federally funded research initiatives.
    The document serves as a comprehensive guide for proposers submitting cost proposals in response to federal government RFPs, specifically for the ARPA-H funding initiative. It outlines how to complete the cost proposal spreadsheet, emphasizing the need for accurate data entry in various tabs, including labor rates and cost details for phases 1 and 2. Proposers must provide adequate supporting data to justify their costs and ensure reasonableness, while adhering to specific instructions regarding cost breakdowns, including direct labor, fringe benefits, overhead costs, and subcontractor expenses. The document stresses the importance of maintaining the integrity of the spreadsheet structure by only using designated input fields and avoiding deletions. Key sections of the proposal require clear identification of labor categories, indirect rates, and any supporting documentation for labor rate calculations. Overall, the instructions aim to facilitate a streamlined evaluation process for government personnel, ensuring that proposals are comprehensive and well-organized to expedite the award process. Compliance with detailed requirements and accurate accounting throughout the proposal is essential for successful bid submission.
    This document outlines a sample Other Transaction Agreement (OTA) between a performer and the Advanced Research Projects Agency for Health (ARPA-H), detailing terms and conditions for funding and collaboration on a research project. The agreement includes provisions regarding scope, term, project management, payment obligations, intellectual property rights, and dispute resolution. It establishes a framework for fixed milestone payments based on deliverables linked to project phases. The performer is responsible for executing the research as per the research description document, while ARPA-H oversees financial and technical monitoring. Key articles cover management structures, financial obligations, reporting requirements, and intellectual property rights, emphasizing the joint efforts to advance health research goals. The agreement maintains the rights to any inventions or data developed, while ensuring compliance with applicable federal laws, security measures, and civil rights mandates. It also contains clauses to regulate disclosure of information and foreign access to intellectual property, emphasizing national security concerns. Overall, this agreement serves as a standardized framework for federal funding of innovative health projects, promoting collaboration while protecting government interests.
    The document outlines a project schedule for a government initiative, indicating the lead organization, title, and key milestones. It includes a Go/No-Go (G/N) decision indicator in Column D and provides start and end dates linked to specific tasks and milestones within a structured framework. Each milestone or task is assigned a corresponding quarter over an extended timeline spanning up to 24 quarters. The schedule appears to facilitate tracking progress and decision-making throughout the project lifecycle, ensuring alignment with the objectives of government RFPs and grants. Overall, the file emphasizes the importance of timing and predefined milestones in the project execution process within a government context.
    The Task Description Document (TDD) outlines the framework for a proposal related to federal government RFPs, federal grants, and state/local RFPs, emphasizing the structured approach needed for executing defined tasks and subtasks. The document mandates detailed descriptions of objectives and methodologies, along with the identification of responsible organizations and the location of work, especially if conducted on university campuses. It requires clear deliverables, the involvement of human or animal subjects, and measurable milestones to track progress. Each task is to be articulated with specific expectations, including reporting obligations to the government. The TDD serves as a guideline to ensure compliance, clarity, and purpose in research and project execution, supporting accountability in using federal funds and resources effectively. Overall, it facilitates transparent communication of project objectives and responsibilities while ensuring alignment with federal requirements.
    The ARPA-H-SOL-25-112 document outlines an Innovative Solutions Opening (ISO) for developing the Imaging Data Exchange (INDEX) platform, intended to streamline access to medical imaging data. The program aims to alleviate the disparity between increasing imaging needs and the shortage of qualified radiologists by utilizing artificial intelligence and machine learning in data management and analysis. INDEX will establish connections between data providers, users, and service providers to create a sustainable, comprehensive repository of medical imaging data, initially focusing on cancer digital pathology, select radiology data, and surgical videos. The initiative is structured in two phases: Phase 0 addresses business model development, while Phase 1 involves system design and enrollment strategies. Key elements include ensuring diverse and representative datasets, establishing a user-friendly data catalog, and facilitating regulatory compliance. Proposals must demonstrate operational viability, with pathways planned for long-term sustainability post-ARPA-H funding. The document emphasizes data accessibility for under-resourced communities and outlines eligibility, proposal submission guidelines, and evaluation criteria for interested entities. Overall, INDEX seeks to promote innovation in medical imaging, enhancing algorithm training and improving patient outcomes via quality data access.
    The Advanced Research Projects Agency for Health (ARPA-H) is initiating the Imaging Data Exchange (INDEX) program to enhance access to medical imaging data, addressing challenges in algorithm development and clinical studies. The program includes a solicitation, ARPA-H-SOL-25-112, inviting proposals to establish a sustainable platform connecting data providers with users through a structured, diverse medical imaging library. The INDEX program comprises three key technical areas: developing a business model (Phase 0), system architecture (Phase 1), and participant enrollment (Phase 1). Proposals must ensure affordability and sustainability of the platform while prioritizing data from under-resourced communities. The initiative aims to foster collaboration among hospitals, research institutions, and data annotators, ultimately facilitating the development of artificial intelligence (AI) and machine learning (ML) solutions for improved healthcare diagnostics. Eligible entities are encouraged to submit detailed plans including data management protocols, compliance with regulatory standards, and strategies for user engagement. The anticipated outcomes include an expansive database of diverse imaging datasets, enhancing the efficiency of AI-driven medical solutions and research. The solicitation emphasizes transparency, collaboration, and a focus on quality data in compliance with FDA standards.
    The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative proposals for the Imaging Data Exchange (INDEX) Program. The primary goal is to create a sustainable platform that connects medical imaging data providers with developers and researchers. This initiative aims to alleviate the shortage of qualified radiologists by leveraging artificial intelligence and machine learning to streamline access to diverse medical imaging data, improving diagnoses and treatments. The program is structured in two phases: Phase 0 focuses on refining business models for INDEX, while Phase 1 entails system architecture design and participant enrollment. Key elements include identifying competitive pricing strategies, ensuring data quality through rigorous validation, and establishing partnerships with service providers for annotation and data management. Successful proposals must address three technical areas: business model development, system design and implementation, and participant engagement, with an emphasis on diversity and inclusion in data representation. The expected data types to be included are whole-slide images for various cancers and select radiology and surgical video data, aiming for significant milestones in data accrual within a defined timeline. This solicitation underscores ARPA-H's commitment to fostering innovation that enhances healthcare outcomes through improved access to quality imaging data.
    The document outlines the Advanced Research Projects Agency for Health’s (ARPA-H) Innovative Solutions Opening (ISO) for the Imaging Data Exchange (INDEX), aiming to improve access to medical imaging data for AI and machine learning applications. The program seeks eligible entities to develop a platform that connects data providers, users, and service providers, ensuring easy, sustainable access to diverse imaging datasets. Key components include creating a robust business model, designing system architecture, and enrolling various participants, such as hospitals and research institutions. The INDEX program is structured in two phases: Phase 0 focuses on refining business models, while Phase 1 encompasses system design and enrollment. It aims to include digital pathology data, radiology, and surgical videos, with specific milestones for data acquisition. The document also emphasizes the need for regulatory compliance, data quality assurance, and diverse demographic representation in datasets. Overall, the INDEX initiative represents a strategic approach to addressing the challenges of data access and utilization in medical imaging, facilitating advancements in healthcare technology through improved AI algorithm development and deployment.
    Lifecycle
    Title
    Type
    Solicitation
    Similar Opportunities
    ARPA-H ImagiNg Data EXchange (INDEX)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing the ImagiNg Data EXchange (INDEX) program, aimed at enhancing access to medical imaging data for the development of artificial intelligence (AI) and machine learning (ML) algorithms in healthcare. The program seeks to establish a sustainable platform that connects data providers and users, focusing on business model development in its initial phase and system architecture in the subsequent phase. This initiative is crucial for facilitating cancer-related research and improving surgical procedures by ensuring efficient access to diverse medical imaging datasets. Interested proposers are encouraged to participate in a Proposers' Day on January 9, 2025, in Seattle, Washington, where they can learn more about the program and register for participation. For further inquiries, potential proposers can contact the INDEX Team at INDEX@arpa-h.gov.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Emerging Health Innovators (EHI) Initiative
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Emerging Health Innovators (EHI) Initiative, aimed at fostering innovative biomedical solutions from early-career researchers and community-based organizations. This initiative invites submissions under two tracks: Technology-Driven Innovation and Community-Centered Innovation, with a focus on addressing significant gaps in health innovation and community health management. Proposals may seek funding up to $350,000 annually for a duration of two years, with a potential extension for a third year, and must adhere to strict compliance guidelines regarding research security, intellectual property, and human and animal subject research. Interested parties should contact the EHI Initiative Team at EHI@ARPA-H.gov, with proposals due by February 5, 2025, following a Proposers' Day on January 8, 2025.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual event titled RAPID Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program focused on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. This event will provide insights into the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to foster engagement and collaboration. The RAPID Program seeks to alleviate the diagnostic challenges faced by rare disease patients by developing innovative diagnostic tools and integrating comprehensive data, with registration for the event opening on December 19, 2024, and closing on February 21, 2025. Interested participants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.
    Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) titled "Rare Disease AI/ML for Precision Integrated Diagnostics" (RAPID). This initiative aims to enhance the diagnostic process for rare diseases by developing advanced diagnostic support tools and optimizing health data collection, particularly for underdiagnosed populations. The RAPID program is critical for addressing the prolonged diagnostic challenges faced by millions of rare disease patients, with a focus on creating comprehensive datasets and fostering collaborations for real-world validation of diagnostic models. Interested applicants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information, with the program spanning a proposed 4.5-year timeline and emphasizing equitable access to diagnostics.
    In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking innovative proposals for the development of In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems. The initiative aims to address the challenges posed by light scattering in biological tissues, which currently limits the effectiveness of non-invasive optical imaging techniques in assessing tissue function and structure. This funding opportunity encourages the advancement of next-generation imaging technologies that can achieve deeper penetration and higher resolution in biological systems. Interested applicants should note that the application due date is March 7, 2025, by 5:00 PM local time, and are encouraged to submit a letter of intent by the same date. For further inquiries, contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
    Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening. This initiative aims to develop innovative in silico human physiology modeling platforms that enhance drug safety assessments and reduce reliance on animal testing in preclinical studies, focusing on leveraging AI/ML for ADME-Tox simulations. The program is structured in two phases, with Phase I dedicated to developing predictive tools and Phase II aimed at integrating these tools into regulatory submissions for IND-enabling studies. Interested parties must submit a solution summary by November 25, 2024, and proposals by February 14, 2025, with all submissions made through the designated online platforms. For further inquiries, contact the CATALYST team via email at CATALYST@arpa-h.gov.